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Introduction  
 
Nutrition support is an essential part of treatment in patients requiring intensive care. Timely provision of 
greater energy and protein intake is associated with lower mortality and a faster time to discharge alive [1, 2].  
However, underfeeding in intensive care patients is commonplace and multi-factorial [3].  In response to 
stress, underfeeding can lead to malnutrition and poor clinical outcomes, including increased mechanical 
ventilation days, infectious complications, length of stay (LOS) in the Intensive Care Unit (ICU) and in hospital, 
with an increase in associated healthcare costs [4-8].    
Enteral nutrition (EN) remains the preferred route of feeding in ICUs, providing both nutritional and non-
nutritional benefits [9-12].  However, there is currently insufficient evidence for the optimal EN delivery 
method in the literature for intensive care patients, with options including Rate Based Feeding (RBF) or bolus 
feeding [13, 14].  Frequent interruptions to EN including routine fasting for procedures and investigations 
exacerbate underfeeding in ICU patients [15, 16] and recent studies have demonstrated that RBF is ineffective 
in addressing this issue [17-20].  Despite this, RBF remains the most common method of EN delivery 
throughout ICUs in Europe.  The recent International Nutrition Survey (INS, 2014/15), demonstrated that 
adequacy of energy and protein in enterally fed ICU patients in Europe was 58% and 54% respectively 
(unpublished data; Darren Heyland, personal communication, 2017).   
A Volume Based Feeding (VBF) approach has been recommended to address the challenges of frequent 
interruptions and optimise the delivery of EN [12,14]; designed to adjust the infusion rate to make up for daily 
interruptions in delivery, enabling a greater volume of EN to be delivered compared to a fixed hourly RBF [18].  
This recommendation for VBF is based on studies in North America [18-21].  To date there are no studies 
evaluating VBF alone and its effect on EN delivery or clinical outcomes outside of North American healthcare 
institutes.  Although the practice of intensive care medicine is universal in most countries, there can be 
significant differences in healthcare and populations in this already heterogeneous patient group; these 
previous VBF studies may not be generalisable to other intensive care populations where differing health 
systems, barriers, patient characteristics and priorities towards nutrition might present [22]. 
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So far there has been no study in the United Kingdom (UK) that addresses whether VBF is a safe and more 
effective method than RBF in improving energy and protein delivery in mechanically ventilated ICU patients. 
We hypothesised that VBF would improve energy and protein delivery without deleterious effects on 
glycaemic control or gastrointestinal tolerance and subsequently, may improve clinical outcome.   
Methodology 
Study Design and Setting 
We conducted a single centre study in an adult, mixed medical and surgical ICU in England, UK between 
January 2015 and March 2017.  This is a cohort study, comparing the usual RBF protocol (cohort 1) to a newly 
implemented VBF Protocol (cohort 2).  Retrospective data were used for RBF participants and prospective data 
were collected for VBF participants, before and after VBF was introduced.  An application to both City, 
University of London’s Senate Research Ethics Committee (Reference number MRes/15-16/40) and UK’s 
Health Research Authority advised that ethical approval was not required for this service evaluation, in that 
these patients would not undergo any additional intrusive procedure to their normal attention, the data 
collected was part of their routine care and further patient consent was not required.   
Participants 
Eligible patients were mechanically ventilated adults (>18 years), requiring EN for >48 hours at any point 
during their first 12 days of stay. Consecutive patients were assessed and selected by a registered dietitian for 
both cohorts.  Patients were excluded for the following reasons: contraindications to EN including bowel 
obstruction, complex bowel surgery (not including post-operative, uncomplicated colonic resections), proximal 
enterocutaneous fistula, short bowel, bowel ischaemia or paralytic ileus; pre-existing or onset of  GI 
intolerance including profuse diarrhoea (5 stools or >750ml/ 24 hours), nausea, vomiting, abdominal 
distension (based on nursing assessment), one episode or more of GRV >250ml; receiving parenteral nutrition; 
aspiration of feed within 48 hours; pregnancy. 
Figure 1 outlines the feeding protocol for our study. Gastric residual volumes were monitored every four to six 
hours and in the absence of a GRV > 250ml, feed rates were advanced every four to six hours.  If there was one 
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or more GRV > 250ml, feeds were initially reduced to a previously tolerated rate or subsequently reduced to 
10-25ml/hour and prokinetic agents were prescribed.  EN was stopped if GRVs were excessive (>500ml).   
Figure 1: Feeding Protocol
ICU Admission 
Initiate standard EN protocol on intensivist’s 
instruction within 48 hours 
Registered dietitian estimates energy & 
protein requirements within 48 -72 hours of 
admission & recommends a polymeric or semi-
elemental EN formula 
Cohort 1: RBF  
(Retrospective data taken from INS 2014-15) 
(e.g. prescribed as 63ml/h over 24h) 
Cohort 2: VBF  
(Prospective data 2016-17) 
(e.g. prescribed as 1500ml in 24 h) 
Strategy if interruption to EN:  
Infusion rate restarted as before 
Strategy if interruption to EN: 
Rate (ml/h) = Remaining Volume (ml)        
 Remaining Time (h) 
(Maximum rate 150ml/h) 
Standard EN protocol: 
Standard polymeric, fibre free feed (1kcal/ml) 
To start at 25ml/h, incremental  to reach 
63ml/h over 24h 
Initiate prokinetics following one GRV >250ml 
If GRVs remain >250ml, insert nasojejunal 
tube 
As per inclusion/ exclusion criteria 
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Recruitment of Rate Based Feeding Patients (Cohort 1) 
Data for RBF patients was collected retrospectively between January and April 2015 as part of an International 
Nutrition Survey (Critical Care Nutrition, INS Study Protocol, 2014/15).   Of the 48 participants recruited for the 
INS, 27 met the inclusion criteria for this study.   
Recruitment of Volume Based Feeding Patients (Cohort 2) 
Consecutive patient data was collected prospectively between March 2016 and March 2017.  Patients 
that were established on the standard EN protocol or RBF regimen were assessed by the dietitian for 
VBF.   
A previously reported VBF protocol [18] was modified and adopted for this study, including using a maximum 
rate of 150ml/hour [17] and the pre-calculated algorithm in which the remaining volume has been rounded to 
one hundred millilitres volumes (instead of 50 millilitres) to simplify calculations (figure 2).  Education before, 
during and after the implementation of VBF protocol was provided for ICU staff by the unit dietitian.    
If patients subsequently developed a poor tolerance to EN, presenting with a single GRV > 250ml, vomiting, 
blood glucose concentration (>18mmol/l) or profuse diarrhoea (defined as 5 stools or 750 mL per 24h period), 
the nurses were permitted to reduce the rate back to a previously tolerated rate or to 25ml/hour, after the 
accepted treatments such as prokinetics for high GRV, change of enteral formula for diarrhoea or insulin 
treatment were unsuccessful. 
Data Collection 
Patient characteristics, demographics, anthropometry, Acute Physiology and Chronic Health Evaluation II 
(APACHE II) [23] score and admission details (date and type of admission, i.e. medical/ surgical and aetiology) 
were recorded on ICU admission. The goals for requirements were determined by the unit dietitian using 
predictive formulas such as 25kcal/kg and 1.2-1.5g/kg for protein [10] or Penn State equation [24].   
The primary outcome measures were the percentage of energy and protein requirements delivered over the 
patients’ ICU stay and included non-nutritious energy from medications such as Propofol.  Data were collected 
until ICU discharge, death, or for a maximum of 12 days; whichever came first.   
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Secondary outcome measures included the number of vomiting episodes, GRV >250ml, prokinetic use, 
morning and highest daily blood glucose concentrations in addition to insulin usage. Mechanical ventilation 
days, ICU and hospital length of stay, ICU and hospital mortality were also collected for 60 days during and 
post ICU admission or until discharge/ death. 
Statistical Analysis 
Statistical analysis was completed using IBM SPSS version 22.0 (U.K version). The power calculation was based 
on a similar study [18] which demonstrated improvement in the delivery of EN calories on percentage means 
of energy delivered for RBF (n=20) at 80.9% (SD = 18.9%) and VBF (n=37) 92.9% (SD = 16.8%) of goal energy 
requirements (P < 0.01), with a medium to high effect size of 0.67.  A priori analysis with G*Power for a 2-
tailed t test of the difference between these independent means (RBF vs VBF), using this effect size, and α 
error level of 0.05 with 80% power resulted in a sample size of 36 patients per group (total 72).  The tests used 
to compare cohort 1 (RBF) and cohort 2 (VBF) were Mann-Whitney U for continuous variables with skewed 
distributions and independent t tests for normally distributed variables.  Chi Square test or Fischer’s Exact test 
were used for the categorical data as appropriate. Some differences in patient characteristics between groups 
were adjusted for using regression methods. Continuous outcomes were analysed using linear regression, with 
a log transformation performed before analysis for those outcomes with positively skewed distributions. 
Logistic regression was used to analyse binary outcomes. Subsequently, multiple regression was used to adjust 
for factors found to vary between the two groups from the initial analyses.   
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Figure 2: Volume Based Feeding Schedule 
  Hours remaining in the day to feed 24h volume 
Goal total mL 
formula per 24h 24 23 22 21 20 19 18 17 16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 
2400 100 104 109 114 120 126 133 141 150 150 150 150 150 150 150 150 150 150 150 150 150 150 150 150 
2300 96 100 105 110 115 121 128 135 144 150 150 150 150 150 150 150 150 150 150 150 150 150 150 150 
2200 92 96 100 105 110 116 122 129 138 147 150 150 150 150 150 150 150 150 150 150 150 150 150 150 
2100 88 91 95 100 105 111 117 124 131 140 150 150 150 150 150 150 150 150 150 150 150 150 150 150 
2000 83 87 91 95 100 105 111 118 125 133 143 150 150 150 150 150 150 150 150 150 150 150 150 150 
1900 79 83 86 90 95 100 106 112 119 127 136 146 150 150 150 150 150 150 150 150 150 150 150 150 
1800 75 78 82 86 90 95 100 106 113 120 129 138 150 150 150 150 150 150 150 150 150 150 150 150 
1700 71 74 77 81 85 89 94 100 106 113 121 131 142 150 150 150 150 150 150 150 150 150 150 150 
1600 67 70 73 76 80 84 89 94 100 107 114 123 133 145 150 150 150 150 150 150 150 150 150 150 
1500 63 65 68 71 75 79 83 88 94 100 107 115 125 136 150 150 150 150 150 150 150 150 150 150 
1400 58 61 64 67 70 74 78 82 88 93 100 108 117 127 140 150 150 150 150 150 150 150 150 150 
1300 54 57 59 62 65 68 72 76 81 87 93 100 108 118 130 144 150 150 150 150 150 150 150 150 
1200 50 52 55 57 60 63 67 71 75 80 86 92 100 109 120 133 150 150 150 150 150 150 150 150 
1100 46 48 50 52 55 58 61 65 69 73 79 85 92 100 110 122 138 150 150 150 150 150 150 150 
1000 42 43 45 48 50 53 56 59 63 67 71 77 83 91 100 111 125 143 150 150 150 150 150 150 
900 38 39 41 43 45 47 50 53 56 60 64 69 75 82 90 100 113 129 150 150 150 150 150 150 
800 33 35 36 38 40 42 44 47 50 53 57 62 67 73 80 89 100 114 133 150 150 150 150 150 
700 29 30 32 33 35 37 39 41 44 47 50 54 58 64 70 78 88 100 117 140 150 150 150 150 
600 25 26 27 29 30 32 33 35 38 40 43 46 50 55 60 67 75 86 100 120 150 150 150 150 
500 21 22 23 24 25 26 28 29 31 33 36 38 42 45 50 56 63 71 83 100 125 150 150 150 
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Results  
Recruitment and Demographics  
A total of 82 patients met the eligibility criteria and were enrolled into the study.  Twenty-seven from 48 
patients were enrolled pre-VBF implementation from the INS study for the RBF group and 55 out of 56 patients 
were enrolled for the VBF group. One patient was excluded from the VBF group after enrolment due to the 
development of a gastrointestinal disorder which required parenteral nutrition. 
There was a significant difference in APACHE II score (RBF 23.4 vs VBF 19.4; p=0.02), type of admission (p=0.02) 
and reason for admission diagnoses (p=0.04) between the groups (see Table 1). Surgical admissions were less 
common in the VBF group (9% vs 30%; p=0.02). The majority of patients were admitted for respiratory 
conditions in both RBF (22.2%) and VBF (59.3%) groups.  The VBF group (n=31, 56%) had a higher number of 
patients with a medical respiratory diagnosis than the RBF group (p=0.004). 
Gastric feeding occurred in most patients; only two patients had post pyloric feeding, both in the VBF group. 
Enteral feeding was interrupted at least once in 96% of patients for both cohorts.  The primary reason for 
these interruptions was fasting for endotracheal intubation or extubation.  The mean hours of all daily 
interruptions between the RBF and VBF was 2.7 vs 2.2 hours per day respectively (p=0.233).  The average time 
to start EN was significantly different with a median of 2 days (IQR 1, 2) for RBF and 1 day (IQR 1, 2) for VBF 
(p=0.01).  The number of days in which patients started VBF from date of admission was 4.5 ± 2.5 days. 
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Table 1. Demographics and Other Baseline Characteristics  
Characteristics Rate Based Feeding 
(n=27) 
Volume Based Feeding 
(n=55) 
P-value 
    
Male sex, No. (%) 15 (56%) 31 (56%) 0.95 
Age, median [IQR], years 63 [51,75] 63 [43,75] 0.57 
APACHE II score, mean ±SD 23.4 ± 6.4 19.4 ± 6.7 0.02 
    
Weight, median [IQR], kg  76 [57, 90] 68 [58, 85]   0.37 
BMI, median [IQR], kg/m2 26.2 [24.0, 28.4] 25.0 [21.3, 29.1] 0.34 
 
Type of admission 
Medical, No. (%)  
Surgical, No. (%) 
 
 
19 (70%) 
8 (30%) 
 
 
50 (91%) 
5 (9%) 
 
 
0.02 
    
    
Admission diagnosis 
Medical, No (%) 
• Cardiovascular /vascular 
• Respiratory 
• Neurological 
• Sepsis  
• Other 
 
Surgical 
• Respiratory 
• Gastrointestinal 
• Head & Neck 
• Other 
 
 
5 (19%) 
6 (22%) 
5 (19%) 
0 (0%) 
3 (11%) 
 
 
1 (4%) 
1 (4%) 
4 (15%) 
2 (7%) 
 
 
7 (13%) 
31 (56%) 
8 (15%) 
2 (4%) 
2 (4%) 
 
 
1 (2%) 
1 (2%) 
2 (4%) 
1 (2%) 
 
 
0.04 
 
0.48 
0.004 
0.65 
N/A 
0.22 
 
 
0.59 
0.59 
0.79 
0.26 
Estimated energy requirements  
 mean ± SD, kcal 
  
Estimated protein requirements 
median [IQR], g 
 
1645 ± 255 
 
 
90 [76, 97] 
1702 ± 279 
 
 
90 [73, 104] 
 
0.38 
 
 
0.66 
Start of EN   median [IQR], days 
 
Start of VBF mean ±SD, days 
 
Patients with interruptions to feed, No. (%) 
 
Interruptions to feed (hours/day) 
 
2 [1, 2] 
 
 
 
26 (96%) 
 
2.7 
 
1 [1, 2] 
 
4.5 ± 2.5 
 
53 (96%) 
 
2.2 
 
0.01 
 
 
      
     1.00 
 
     0.77 
 
APACHE II, Acute Physiology and Chronic Health Evaluation II, BMI, Body Mass Index; ICU, Intensive Care Unit; EN, enteral 
nutrition; VBF, volume based feeding.; GRV, Gastric Residual Volume. 
kg, kilograms; m, metres; kcal, kilocalories; g, grams;  
Data are reported as mean ± standard deviation (SD), or median and interquartile range (IQR); No, number; N/A, Not 
Applicable 
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Table 2. Mean Daily Delivery of Energy and Protein from Rate Based and Volume Based Feeding 
Outcome Analysis Rate 
 Based 
Feeding 
(n=27) 
Volume 
Based 
feeding 
(n=55) 
Difference 
Mean (95% CI) 
P value 
      
Energy (kcal)  Unadjusted 737 ± 282 1308 ± 239 570 (452, 689) <0.001 
received  Adjusted (*) - - 488 (318, 629) <0.001 
      
% Energy  Unadjusted 46.1 ± 19.7 77.8 ± 13.4 31.7 (24.4, 39.1) <0.001 
requirements  Adjusted (*) - - 25.2 (15.0, 35.5) <0.001 
      
Energy (kcal)  Unadjusted 826 ± 256 1383 ± 245 557 (441, 674) <0.001 
received (+) Adjusted (*) - - 492 (327, 666) <0.001 
      
% Energy  Unadjusted 51.6 ± 18.6 82.2 ± 13.8 30.6 (23.3, 37.9) <0.001 
requirements (+) Adjusted (*) - - 26.2 (16.1, 36.2) <0.001 
      
Protein (g) received Unadjusted 33.4 ± 14.1 64.7 ± 15.0 31.2 (24.4, 38.1) <0.001 
 Adjusted (*) - - 25.3 (15.7, 34.9) <0.001 
      
% Protein  Unadjusted 40.1 ± 18.9 72.9 ± 15.0 32.8 (25.2, 40.5) <0.001 
requirements Adjusted (*) - - 25.2 (14.5, 35.9) <0.001 
      
      
Energy delivered 
 (kcal / kg) 
 10.8 20.3   
      
Protein delivered (g/kg)  0.44 0.95   
      
Kcal, kilocalories; kg, kilograms; g, grams 
Summary statistics are mean ± standard deviation or number (percentage) in each category  
(*) Adjusted for: APACHE II score, admission type, method of estimated energy requirement, time to start enteral nutrition  
(+) Including energy from Propofol  
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Primary Outcome 
 Delivery of Energy and Protein 
Table 2 reports the difference in energy and protein delivered between the groups.  The VBF patients received 
a significantly greater percentage of prescribed energy, including non-nutritious energy from Propofol (82% 
versus 52%, p<0.001) and protein (73% versus 40%, p<0.001) compared to RBF patients. There was also a 
significant difference in percentage energy delivery from EN alone (78% versus 46%, p<0.001).  The daily mean 
energy and protein calculated over ≤12days indicated that the RBF group received 11kcal/kg and 0.4g 
protein/kg in contrast to 20kcal/kg and 1.0g protein/kg for the VBF group.   
Secondary Outcomes  
Safety Outcomes  
After adjusting for the differences in patient characteristics, there was no significant difference in glycaemic 
control, units of insulin administered, episodes of GRV >250mls and prokinetic use between the two groups 
(Table 3). Vomiting was higher in the RBF group, but this difference was non-significant after adjusting for 
confounding factors, such as APACHE II score, admission type, time to start EN and method of estimated 
energy requirements (p=0.08).   
Patient Outcomes  
The results demonstrated a significant difference between groups in the number of days of mechanical 
ventilation in the unadjusted analysis (p=0.002), which was no longer statistically significant (p= 0.12) after 
controlling for APACHE II score, type of admission and time to start EN. There was no significant difference in  
both ICU and hospital length of stay or ICU and hospital mortality.  
 
 
12 
 
Rates of Enteral Nutrition Infusion During VBF 
The mean ‘average’ rate of infusion for VBF was 54ml/h ± 9.0 and the mean ‘maximum’ rate was 85ml/h ± 
32.6.  However, in six cases, rates were increased up to a maximum 150ml/hour with no complications 
observed. 
Table 3: Safety and Patient Outcomes 
Outcome Analysis Rate 
 Based  
Feeding 
(n=27) 
Volume 
Based  
Feeding 
(n=55) 
Difference (+) 
(95% CI) 
P value 
      
Glycaemic control      
Hypoglycaemic event Unadjusted 1 (4%) 3 (5%) - 1.00 
      
Highest blood glucose  Unadjusted 11.7 ± 3.2 11.6 ± 2.8 -0.2 (-1.5, 1.2) 0.80 
concentrations (mmol/l) Adjusted (*) - - 0.1 (-1.9, 2.0) 0.94 
      
Morning blood glucose  Unadjusted 8.4 ± 1.9 8.6 ± 1.3 0.2 (-0.5, 0.9) 0.57 
concentrations (mmol/l) Adjusted (*) - - 0.5 (-0.5, 1.6) 0.33 
      
Insulin (daily units) Unadjusted 4 [0, 52] 18 [0, 53] 1.83 (0.78, 4.34) 0.17 
 Adjusted (*) - - 1.21 (0.36, 4.10) 0.75 
      
Gastrointestinal tolerance      
Vomiting Unadjusted 7 (26%) 5 (9%) 0.29 (0.08, 1.01) 0.05 
 Adjusted (*) - - 0.21 (0.04, 1.21) 0.08 
      
≥1 GRVs > 250ml Unadjusted 2 (7%) 7 (13%) 1.82 (0.35, 9.44) 0.47 
 Adjusted (*) - - 1.82 (0.18, 18.7) 0.62 
      
Prokinetic use Unadjusted 5 (19%) 5 (9%) 0.44 (0.12, 1.67) 0.23 
 Adjusted (*)   0.39 (0.05, 3.04) 0.37 
 
Mechanical ventilation  Unadjusted 6 [4, 10] 9 [6, 15] 1.76 (1.23, 2.51)   0.002 
days Adjusted (*)   1.46 (0.91, 2.35) 0.12 
 
      
Length of ICU stay  Unadjusted 10 [6, 15] 11 [7, 19] 1.24 (0.88, 1.75) 0.22 
(days) Adjusted (*) - - 1.02 (0.63, 1.66) 0.93 
 
Length of hospital stay  Unadjusted 13 [10, 44] 23 [11, 48] 1.14 (0.75, 1.73) 0.52 
(days)  Adjusted (*) - - 0.90 (0.49, 1.64) 0.72 
      
Mortality      
ICU mortality Unadjusted 3 (11%) 10 (18%) 1.78 (0.45, 7.08) 0.42 
 Adjusted (*) - - 8.67 (0.95, 79.4) 0.06 
      
Hospital mortality Unadjusted 6 (22%) 12 (22%) 0.98 (0.32, 2.96) 0.97 
 Adjusted (*) - - 3.64 (0.66, 20.1) 0.14 
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GRV Gastric Residual Volumes ICU Intensive Care Unit  
Summary statistics are mean ± standard deviation, median [inter-quartile range] or number (%) in each category  
(*) Adjusted for: APACHE II score, admission type, method of estimated energy requirement, time to start enteral nutrition 
(EN)  
(+) Difference between groups reported as mean difference (normally distributed continuous variables), ratios (skewed 
continuous variables) or odds ratios (binary variables)  
Discussion 
This study established that VBF can significantly increase energy and protein delivery in the first 12 days of 
intensive care admission.  These findings offer further evidence that VBF is a safe, alternative strategy in 
achieving target energy and protein goals in both clinical and research settings in spite of frequent 
interruptions to EN; intending to minimise nutritional deficits which have been associated with improving 
clinical outcomes [1, 4, 6, 7].  Volume based feeding has previously been used as part of a multi strategy 
protocol [17, 20, 21] and has shown to increase energy and protein delivery but it is difficult to determine if 
this increase was attributed entirely to VBF.  Other contributing components from these studies include the 
routine use of protein supplementation (≥24g protein) at initiation of EN; use of a semi-elemental or peptide 
feed (1.0-1.5kcal/ml); initiation of EN at target rate; use of prophylactic prokinetics on initiation of EN and 
higher GRV threshold [17, 20, 21].  Whilst other VBF studies have also successfully improved the delivery of 
percentage goal energy [18, 19], this is the first study to demonstrate an increase in protein delivery from VBF 
alone.   
Previous work has demonstrated that during interrupted EN days, there was a statistically significant 
difference in goal energy delivered between VBF (78%) and RBF (62%) [18].  Our study epitomises the 
perpetual interruptions to EN, where 96% (n=79) of patients experienced routine interruptions of 2.7 hours 
per day (RBF) and 2.2 hours per day (VBF), with no significant difference between the two groups.  We 
identified various reasons for interruptions to EN during our study, primarily fasting for endotracheal 
intubation or extubation; in addition to medical investigations or procedures, drug administration, an 
inaccessible gastrointestinal tract or enteral tube displacement.   The delays in extubation or possible re-
intubation, resulted in EN being held for long periods and on consecutive days, leading to difficulties making 
up for the entirety of EN hours missed.   
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Observational studies on mechanically ventilated patients have demonstrated that providing at least 80% of 
energy [27] and protein [28] target was associated with improved clinical outcomes, in particular patients with 
a higher nutritional risk [2].  However, there is currently debate on the most efficacious dose of energy and 
protein to optimise patient outcomes, especially in the early phase of critical illness.  Current guidelines 
recommend 20-25kcal/kg and 1.2-2.0g protein per day [10, 12]. Although our VBF group succeeded in meeting 
80% of goal energy, this did not translate into improved clinical outcomes, with the study insufficiently 
powered for such aspects.  In addition, despite a significant increase in protein delivery, it fell short at 73%.  
The barriers in providing adequate protein can be related to the additional provision of energy from non-
nutritious sources such as Propofol, glucose containing infusions and citrate anticoagulation used in 
continuous venovenous haemofiltration [29]; which often requires a reduction in energy from EN, 
subsequently reducing protein provision.  Patients will benefit from EN formulas modified to avoid overfeeding 
exogenous energy and using higher protein formulas or protein supplementation together with VBF [17].  
This is a study exploring the delivery of energy and protein, safety and clinical outcomes of VBF, which is a 
relatively novel approach to EN delivery in the UK.  It measures the impact of VBF on both gastrointestinal 
tolerance and glycaemic control.  Our results suggest that VBF was delivered safely, with no significant 
difference in gastrointestinal tolerance, including GRV, vomiting, prokinetic use, glycaemic control and insulin 
use compared to RBF.  The intensive monitoring of GRVs for EN tolerance is currently under question but was 
included as another measure of safety for this study.  Holding or reducing EN is common after a GRV >250ml, 
contributing to further interruptions and resulting in a reduction in the volume of EN received and an energy 
deficit [5].  Recent research findings [25,26] of patients predominantly with medical diagnoses indicate that 
monitoring GRVs may be unnecessary and that this, in turn, may assist in further reducing EN interruptions. 
This study found that GRVs were unaffected by VBF despite being perceived as more aggressive and less likely 
to be tolerated with potentially faster rates than RBF.   Similar studies comparing VBF with RBF, demonstrated 
no difference in gastrointestinal tolerance and pulmonary aspiration [18], ventilator acquired pneumonia 
(VAP) and urinary tract infections [19].  The anticipated concerns relating to the implementation of VBF in ICUs 
are the higher rates of hourly EN delivery, leading to vomiting and aspiration of EN resulting in an increase in 
mechanical ventilation days.  Our study demonstrated that irrespective of higher respiratory diagnoses in our 
VBF group (n=31, 56%) than the RBF group (n=6, 22.2%) which also might account for the higher number of 
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mechanically ventilated days, VBF strategy had no significant effect (p= 0.12).  Our findings together with 
several studies [17-21] suggest vomiting was also not increased (p= 0.08).  This is presumably related to VBF 
patients in this study being selected based on having good gastrointestinal function and previously tolerating 
EN.  
Data relating to nutritional intake and tolerance was collected from day 1 of admission up to day 12 or until 
discharge from ICU.  We recognise that EN delivery in the early acute phase is often difficult and it remains 
uncertain whether VBF is a suitable strategy at admission [13].  However, it is conceivable that VBF may be 
beneficial when patients are established on EN post-acute phase and in their recovery phase, over a longer ICU 
stay.  The average number of days from admission to start of VBF in this  study was 4.5 ± 2.5.   
Our study was conducted in a mixed medical and surgical adult ICU in England, UK.  The characteristics of 
patients were broadly representative and, as a pragmatic effectiveness study, probably represent the reality of 
current nutritional practice in critical care in the UK.  It is notable that the mean APACHE II score for VBF and 
RBF patients recruited to this study was 23.4 ± 6.4 and 19.4 ± 6.7 respectively, similar to the mean APACHE II 
(20.5 ± 8.5) of intensive care patients in the UK [22].  A similar study by Haskins et al investigated VBF on 
intensive care patients in United States America (USA) with median APACHE II scores of 10 (8, 16) and 17 (12, 
19) for RBF and VBF groups respectively [19].  The original single centre (USA) VBF study by McClave et al [18] 
confirmed safe and improved energy delivery in patients with a mean Simplified Acute Physiology Score (SAPS) 
score of 21.7 ±  9.0 19.5 ± 9.3.  Our UK study demonstrated that VBF can be tolerated in patients with a higher 
disease severity.   Although the practice of critical care medicine is universal in most countries, there can be 
differences in disease severity and populations in this already heterogeneous patient group [22] and these 
previous VBF studies [18,19] might not be generalisable to critical care populations outside North America.   
Strengths of this study include a heterogeneous, adult population in a UK single centre ICU that had pre-
existing, established protocols and guidelines for managing nutritional support, raised GRVs and glycaemic 
control, reflecting good mainstream practice [9, 10, 12].  Despite using a convenience sample from the INS 
data for cohort 1, the same inclusion and exclusion criteria was used for selection for both cohorts. 
The non-randomised controlled design, single centre population that had a greater representation of medical 
rather than surgical patients may limit generalisability.  Recent studies using a multi-strategy EN protocol 
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including VBF have demonstrated an improvement of nutrition delivery in medical patients [3, 17, 21] but did 
not have the same effect in surgical patients [30].  The low frequency of gastrointestinal complications for our 
VBF group could be due to the selection of patients that were already established on EN.  Comorbidities and 
Nutrition Risk in Critically ill (NUTRIC) or other nutrition screening scores were not collected but might have 
influenced secondary outcomes such as lower mortality and faster time to discharge alive, in that patients with 
higher nutritional risk may benefit more from optimal provision of energy and protein compared with those 
with lower risk [2, 31, 32,].   
 Other limitations include, the small sample size and therefore, underpowered to determine statistical 
significance for secondary outcomes.  The regular education sessions held on VBF for ICU nurses and doctors 
possibly heightened awareness of nutrition on the unit, contributing to better EN delivery in the VBF cohort.  
The patients for the two cohorts were recruited over a year apart. During that time the ICU updated its’ GRV 
threshold to 350ml (from 250ml) before VBF was implemented, therefore, to avoid bias, GRVs recorded by 
nurses at 250ml or above were considered as ‘high’ for both groups.  Protein supplementation was also 
introduced during this period however, it was not routine practice.  When protein supplementation was 
prescribed in 19% of the intervention group, nurses did not routinely administer it, having little effect on total 
protein intake.    Finally, indirect calorimetry was not available and predictive equations were used which are 
less reliable [33, 34].  
In future, a more robust, adequately powered randomised controlled trial, including more surgical patients is 
recommended to investigate the impact of the VBF protocol on nutrition delivery.  The use of body 
composition analysis, functional or health related quality of life (HRQOL) measures as primary outcomes to 
evaluate nutrition intervention may be more suitable than mortality and infectious complications [35]. 
In conclusion, this study described an alternative strategy to the RBF protocol.  It confirmed that compared to 
RBF, VBF protocol can be successfully implemented to significantly enhance the delivery of EN safely, with no 
adverse effect on glycaemic control and gastrointestinal tolerance.  However, despite this improvement, there 
was no beneficial effect observed on clinical outcomes, as it was underpowered to do so.  This study’s findings 
should encourage the development of a robust, adequately powered randomised controlled trial to investigate 
the impact of this safe VBF protocol on nutrition delivery and appropriate clinical outcomes. 
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